SARS-CoV-2 infection and antibody seroprevalence in routine surveillance patients, healthcare workers and general population in Kita region, Mali: an observational study 2020–2021

• Published in: BMJ open 2022-06, Vol.12 (6), p.e060367
• Main Authors: Alber, Dagmar, Haidara, Fadima Cheick, Luoma, Juho, Adubra, Laura, Ashorn, Per, Ashorn, Ulla, Badji, Henry, Cloutman-Green, Elaine, Diallo, Fatoumata, Ihamuotila, Rikhard, Klein, Nigel, Martell, Owen, Onwuchekwa, Uma U, Samaké, Oumar, Sow, Samba O, Traore, Awa, Wilson, Kevin, Ducker, Camilla, Fan, Yue-Mei
• Format: Article
• Language: English
• Subjects: Antibodies; Antibodies, Viral; Child; COVID-19; COVID-19 - diagnosis; COVID-19 - epidemiology; Epidemiology; Health facilities; Health Personnel; Health surveillance; Humans; Immune system; Mali - epidemiology; Medical personnel; Nurses; Observational studies; respiratory infections; SARS-CoV-2; Seroepidemiologic Studies; Severe acute respiratory syndrome coronavirus 2
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2021-060367

ObjectiveTo estimate the degree of SARS-CoV-2 transmission among healthcare workers (HCWs) and general population in Kita region of Mali.DesignRoutine surveillance in 12 health facilities, HCWs serosurvey in five health facilities and community serosurvey in 16 villages in or near Kita town, Mali.SettingKita region, western Mali; local health centres around the central (regional) referral health centre.ParticipantsPatients in routine surveillance, HCWs in local health centres and community members of all ages in populations associated with study health centres.Main outcome measuresSeropositivity of ELISA test detecting SARS-CoV-2-specific total antibodies and real-time RT-PCR confirmed SARS-CoV-2 infection.ResultsFrom 2392 routine surveillance samples, 68 (2.8%, 95% CI: 2.2% to 3.6%) tested positive for SARS-CoV-2 by RT-PCR. The monthly positivity rate was 0% in June–August 2020 and gradually increased to 6% by December 2020 and 6.2% by January 2021, then declined to 5.5%, 3.3%, 3.6% and 0.8% in February, March, April and May 2021, respectively. From 397 serum samples collected from 113 HCWs, 175 (44.1%, 95% CI: 39.1% to 49.1%) were positive for SARS-CoV-2 antibodies. The monthly seroprevalence was around 10% from September to November 2020 and increased to over 40% from December 2020 to May 2021. For community serosurvey in December 2020, overall seroprevalence of SARS-CoV-2 antibodies was 27.7%. The highest age-stratified seroprevalence was observed in participants aged 60–69 years (45.5%, 95% CI: 32.3% to 58.6%). The lowest was in children aged 0–9 years (14.0%, 95% CI: 7.4% to 20.6%).ConclusionsSARS-CoV-2 in rural Mali is much more widespread than assumed by national testing data and particularly in the older population and frontline HCWs. The observation is contrary to the widely expressed view, based on limited data, that COVID-19 infection rates were lower in 2020–2021 in West Africa than in other settings.